3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Solid Tumors Harboring NTRK Fusion
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Insulin-Like Growth Factor I, Resistance To
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Advanced Solid Tumor
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
36
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
29
Papillomavirus Vaccines
22
Vaccines
11
Human Papillomavirus Recombinant Vaccine nonavalent
11
Radiotherapy, Intensity-Modulated
7
Human Papillomavirus DNA Tests
7
Colposcopy
7
Cisplatin
7
Educational Status
6
Carboplatin
6
Blood Specimen Collection
6
Vaccines, Synthetic
5
Specimen Handling
5
Early Intervention, Educational
5
Vaginal Smears
4
Methods
4
Engerix-B
4
fludarabine
3
epigallocatechin gallate
3
artesunic acid
3
artemisinin
3
Watchful Waiting
3
Surveys and Questionnaires
3
Patient Navigation
3
Paclitaxel
3
Imiquimod
3
Hepatitis A Vaccines
3
Cyclophosphamide
3
halofantrine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Papillomavirus Infections
×
Receptor Protein-Tyrosine Kinases
×
Clear all
NCT01588301
2014-09-12
APACHE-2
University Hospital, Tours
Phase EARLY_PHASE1
Completed
5,998 enrolled